Abstract:BACKGROUND:As the most abundant protein in the blood, human serum albumin (HSA) plays an important role in maintaining plasma oncotic pressure and fluid balance between the body's compartments. HSA is thus widely used in the clinic to treat diseases. However, the shortage of and safety issues arising from using plasma HSA (pHSA) underscore the importance of recombinant HSA (rHSA) as a promising substitute for pHSA.SCOPE OF REVIEW:Here, we review the production of rHSA, from expression to downstream processing, and highlight the scalability and cost-effectiveness of the two main expression platforms. We also discuss the biosafety of commercially available pharmaceutical rHSA with respect to impurities and contaminants, followed by an analysis of recent progress in preclinical and clinical trials. We emphasise the challenges of producing pharmaceutical-grade rHSA.MAJOR CONCLUSIONS:rHSA can be highly expressed in various hosts and seems to be identical to pHSA. rHSA generated from yeast appears to be as efficient and safe as pHSA in a series of preclinical and clinical trials, whereas rHSA from rice seeds exhibits great potential for more cost-effective production. Cost-effective products with no adverse effects will likely play a vital role in future human therapeutics.GENERAL SIGNIFICANCE:Our understanding of pharmaceutical-grade rHSA production has improved with respect to expression hosts, biochemical properties, downstream processing, and the detection and removal of impurities. However, due to the large dosages required for clinical applications, the production of sufficient quantities of rHSA still presents challenges. This article is part of a Special Issue entitled Serum Albumin.

Applications of human and bovine serum albumins in biomedical engineering: A review

Progress of Recombinant Human Serum Albumin in Pharmaceutical Application

Bovine Serum Albumin as a Versatile Platform for Cancer Imaging and Therapy

Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin

Insight on Serum Albumin: from Structure and Biological Properties to Functional Biomaterials for Bone Repair.

Bovine Serum Albumin-Based Hydrogels: Preparation, Properties and Biological Applications

Research progress on albumin-based hydrogels: Properties, preparation methods, types and its application for antitumor-drug delivery and tissue engineering

Molecular and biological characteristics of human serum albumin

Application of Albumin in Drugs Delivery System

Albumin, an interesting and functionally diverse protein, varies from 'native' to 'effective' (Review)

Clinical applications of albumin in the management of cirrhosis and its complications

Albumin as Drug Carriers

Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Heterocoagulation as a facile route to prepare stable serum albumin-nanoparticle conjugates for biomedical applications: synthetic protocols and mechanistic insights

Human Serum Albumin from Recombinant DNA Technology: Challenges and Strategies

Serum Albumin in Health and Disease: Esterase, Antioxidant, Transporting and Signaling Properties

Recombinant Human Serum Albumin Fusion Proteins and Novel Applications in Drug Delivery and Therapy

Research progress of serum albumin in the field of drug delivery

Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy

Recent Advancements in Serum Albumin-Based Nanovehicles Toward Potential Cancer Diagnosis and Therapy

Structure and Enzymatic Activities of Human Serum Albumin.